Alliancebernstein L.P. Artivion, Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Artivion, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 49,328 shares of AORT stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,328
Previous 49,328
-0.0%
Holding current value
$1.19 Million
Previous $1.31 Million
8.07%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$160 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$67.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$67.5 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$66.2 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$57 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $974M
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...